Enlivex 裁员 60%、砍掉临床前研发并大幅下调高管薪酬

Enlivex lays off 60% of employees, scraps preclinical R&D and gives execs ‘substantial’ salary cuts - Fierce Biotech

导读

Enlivex 宣布裁员 60%，砍掉临床前研发业务，并对高管团队实施"大幅"降薪。